EU OKs Teva's $40B Allergan Buy Pending Cuts In UK, Ireland
The European Commission on Thursday approved Teva's proposed $40.5 billion purchase of Allergan's generics business, contingent on the companies getting rid of significant assets in Ireland, the U.K. and Iceland....To view the full article, register now.
Already a subscriber? Click here to view full article